Zobrazeno 1 - 10
of 18
pro vyhledávání: '"C Gianna Hoffman-Luca"'
Autor:
C Gianna Hoffman-Luca, Chao-Yie Yang, Jianfeng Lu, Daniel Ziazadeh, Donna McEachern, Laurent Debussche, Shaomeng Wang
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128807 (2015)
SAR405838 is a potent and specific MDM2 inhibitor currently being evaluated in Phase I clinical trials for the treatment of human cancer. Using the SJSA-1 osteosarcoma cell line which harbors an amplified MDM2 gene and wild-type p53, we have investig
Externí odkaz:
https://doaj.org/article/e0f16c2bfe2e4121ac305783ca6bfeb1
Autor:
Shaomeng Wang, Laurent Debussche, Wei Sun, Yujun Zhao, Donna McEachern, Daniel Ziazadeh, C. Gianna Hoffman-Luca
Supplemental Figure S5 and Figure S6. Figure S5. Testing the role of BAX and BAK for the activity of ABT-263 or SAR in MV4;11 cells. Figure S6. Evaluation of the role of p53 for the activity of SAR and ABT-263 in the MV4;11 cell line.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16a736b14d30e851333b8a3112e5071
https://doi.org/10.1158/1078-0432.22459064
https://doi.org/10.1158/1078-0432.22459064
Autor:
Shaomeng Wang, Laurent Debussche, Wei Sun, Yujun Zhao, Donna McEachern, Daniel Ziazadeh, C. Gianna Hoffman-Luca
Supplemental Figure S4. Further Characterization of MV4;11 sublines obtained from in vitro treatment with ABT-263 or SAR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40dac23928286374dfb3c8c8c028198
https://doi.org/10.1158/1078-0432.22459067.v1
https://doi.org/10.1158/1078-0432.22459067.v1
Autor:
Shaomeng Wang, Laurent Debussche, Wei Sun, Yujun Zhao, Donna McEachern, Daniel Ziazadeh, C. Gianna Hoffman-Luca
Supplemental Table S1, Table S2 and Table S3. Table S1. Sequencing of p53 in RS4;11 cell lines. Table S2. Combination index analysis of and SAR405838 and ABT-263 in the RS4;11 and MV4;11 cell lines in cell growth assay. Table S3. Combination index an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1746ce506979150c13a3f057bc877863
https://doi.org/10.1158/1078-0432.22459055
https://doi.org/10.1158/1078-0432.22459055
Autor:
Shaomeng Wang, Laurent Debussche, Wei Sun, Yujun Zhao, Donna McEachern, Daniel Ziazadeh, C. Gianna Hoffman-Luca
Purpose: Two clinical-stage anticancer drugs, the Bcl-2 inhibitor ABT-263, and the MDM2 inhibitor SAR405838 achieve complete tumor regression in animal models of leukemia but also induce acquired resistance. Elucidation of acquired resistance mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4942a9966acc75b55040667e28c93c84
https://doi.org/10.1158/1078-0432.c.6524123
https://doi.org/10.1158/1078-0432.c.6524123
Autor:
C. Gianna Hoffman-Luca, Yujun Zhao, Donna McEachern, Shaomeng Wang, Laurent Debussche, Wei Sun, Daniel Ziazadeh
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(11)
Purpose: Two clinical-stage anticancer drugs, the Bcl-2 inhibitor ABT-263, and the MDM2 inhibitor SAR405838 achieve complete tumor regression in animal models of leukemia but also induce acquired resistance. Elucidation of acquired resistance mechani
Publikováno v:
Dalton transactions (Cambridge, England : 2003). (45)
The iron nitrosyl [(PaPy2Q)Fe(NO)](ClO4)2 (2), derived from the quinoline-based ligand PaPy2QH (N,N-bis(2-pyridylmethyl)amine-N-ethyl-2-quinoline-2-carboxamide, where H is dissociable proton) has been characterized by spectroscopy and X-ray diffracti
Autor:
Chao Yie Yang, Jianfeng Lu, C. Gianna Hoffman-Luca, Donna McEachern, Daniel Ziazadeh, Shaomeng Wang, Laurent Debussche
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128807 (2015)
PLoS ONE
PLoS ONE
SAR405838 is a potent and specific MDM2 inhibitor currently being evaluated in Phase I clinical trials for the treatment of human cancer. Using the SJSA-1 osteosarcoma cell line which harbors an amplified MDM2 gene and wild-type p53, we have investig
Autor:
Daniel Ziazadeh, C. Gianna Hoffman-Luca, Laurent Debussche, Yujun Zhao, Wei Sun, Donna McEachern, Shaomeng Wang
Publikováno v:
Molecular Cancer Therapeutics. 12:C250-C250
Acquired resistance of tumor cells to anticancer drugs is a major cause of cancer therapy failure in the clinic. In this study, we have investigated the acquired resistance mechanisms in vitro and in vivo for two novel anticancer drugs currently in c
Publikováno v:
Dalton Transactions: An International Journal of Inorganic Chemistry; 12/7/2007, Vol. 2007 Issue 45, p5268-5274, 7p